Phenformin, a mitochondrial inhibitor and analog of metformin, has been shown to selectively induce apoptosis in STK11-deficient NSCLC cells and prolong survival in murine models of NSCLC tumors with KRAS and STK11 mutations (131). This evidence concerns the gene STK11 and non-small cell lung carcinoma.